DK2344523T3 - Gas-kombinationsvacciner og lægemidler - Google Patents
Gas-kombinationsvacciner og lægemidler Download PDFInfo
- Publication number
- DK2344523T3 DK2344523T3 DK09786278.3T DK09786278T DK2344523T3 DK 2344523 T3 DK2344523 T3 DK 2344523T3 DK 09786278 T DK09786278 T DK 09786278T DK 2344523 T3 DK2344523 T3 DK 2344523T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceuticals
- combination vaccines
- gas combination
- gas
- vaccines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Gram-positive bacteria
- C07K16/1275—Streptococcus (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Otolaryngology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9755108P | 2008-09-17 | 2008-09-17 | |
| PCT/IB2009/006949 WO2010076618A1 (en) | 2008-09-17 | 2009-09-17 | Combination gas vaccines and therapeutics |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2344523T3 true DK2344523T3 (da) | 2016-04-18 |
Family
ID=41508998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09786278.3T DK2344523T3 (da) | 2008-09-17 | 2009-09-17 | Gas-kombinationsvacciner og lægemidler |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US20100136041A1 (OSRAM) |
| EP (1) | EP2344523B1 (OSRAM) |
| JP (2) | JP5680536B2 (OSRAM) |
| CN (1) | CN102356090B (OSRAM) |
| AU (1) | AU2009334428B2 (OSRAM) |
| BR (1) | BRPI0919236A8 (OSRAM) |
| CA (1) | CA2737453A1 (OSRAM) |
| DK (1) | DK2344523T3 (OSRAM) |
| ES (1) | ES2566740T3 (OSRAM) |
| HR (1) | HRP20160306T1 (OSRAM) |
| HU (1) | HUE027618T2 (OSRAM) |
| MX (1) | MX2011002760A (OSRAM) |
| NZ (1) | NZ591633A (OSRAM) |
| PL (1) | PL2344523T3 (OSRAM) |
| SI (1) | SI2344523T1 (OSRAM) |
| SM (1) | SMT201600125B (OSRAM) |
| WO (1) | WO2010076618A1 (OSRAM) |
| ZA (1) | ZA201102005B (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0210128D0 (en) * | 2002-05-02 | 2002-06-12 | Chiron Spa | Nucleic acids and proteins from streptococcus groups A & B |
| PL2493498T3 (pl) | 2009-10-30 | 2017-08-31 | Glaxosmithkline Biologicals Sa | Oczyszczanie sacharydów otoczkowych staphylococcus aureus typu 5 i typu 8 |
| CN103239734B (zh) * | 2012-02-10 | 2016-02-24 | 北京艾棣维欣生物技术有限公司 | 用于预防和/或治疗呼吸道合胞病毒感染的疫苗 |
| GB201206366D0 (en) * | 2012-04-11 | 2012-05-23 | Absynth Biologics Ltd | Bacterial vaccine |
| RU2662970C2 (ru) * | 2012-09-18 | 2018-07-31 | Новартис Аг | Везикулы наружной мембраны |
| CN106794236B (zh) | 2014-04-15 | 2021-09-03 | 格里菲斯大学 | A群链球菌疫苗 |
| WO2015169773A2 (en) * | 2014-05-07 | 2015-11-12 | Glaxosmithkline Biologicals S.A. | Mutants of spy0269 |
| US10329601B2 (en) * | 2015-12-28 | 2019-06-25 | Ionian Technologies, Inc. | Nicking and extension amplification reaction (NEAR) of Streptococcus species |
| CN112442472B (zh) * | 2020-11-30 | 2023-05-26 | 四川大学华西医院 | 抗艰难梭菌的重组乳酸乳球菌、活载体疫苗及其制备方法 |
| JP7601913B2 (ja) * | 2021-01-19 | 2024-12-17 | デンカ株式会社 | タンパク質、溶血性連鎖球菌ワクチン、ｄｎａ、ベクター、形質転換体、タンパク質を製造する方法、バキュロウイルス、アグロバクテリウム、ラテックス粒子、キット及び抗ストレプトリジンｏ抗体の測定方法 |
| GB202215414D0 (en) | 2022-10-18 | 2022-11-30 | Glaxosmithkline Biologicals Sa | Vaccine |
| CN116875520B (zh) * | 2023-07-12 | 2024-06-14 | 吉林农业大学 | 表达核糖体失活蛋白的乳酸菌及其在抗轮状病毒中的应用 |
| CN120005039B (zh) * | 2025-01-10 | 2025-12-19 | 遵义医科大学珠海校区 | HtsA-SLOdm融合蛋白及其在制备A族链球菌疫苗中的应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8827038D0 (en) * | 1988-11-18 | 1988-12-21 | Kehoe M | Streptolysin o antigens & uses |
| US5866135A (en) * | 1994-04-21 | 1999-02-02 | North American Vaccine, Inc. | Group A streptococcal polysaccharide immunogenic compositions and methods |
| JP4875490B2 (ja) * | 2003-07-31 | 2012-02-15 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | ＳｔｒｅｐｔｏｃｏｃｃｕｓＰｙｏｇｅｎｅｓについての免疫原組成物 |
| WO2006042027A2 (en) * | 2004-10-08 | 2006-04-20 | Novartis Vaccines And Diagnostics Inc. | Immunogenic and therapeutic compositions for streptococcus pyogenes |
| AU2007348285A1 (en) * | 2006-10-30 | 2008-09-12 | Novartis Ag | Immunogenic and therapeutic compositions for streptococcus pyogenes |
| CA2699513C (en) * | 2007-09-12 | 2018-03-13 | Novartis Ag | Gas57 mutant antigens and gas57 antibodies |
| BRPI0821240B8 (pt) * | 2007-12-21 | 2022-10-04 | Novartis Ag | formas mutantes de estreptolisina o |
-
2009
- 2009-09-17 MX MX2011002760A patent/MX2011002760A/es active IP Right Grant
- 2009-09-17 NZ NZ591633A patent/NZ591633A/xx not_active IP Right Cessation
- 2009-09-17 BR BRPI0919236A patent/BRPI0919236A8/pt not_active Application Discontinuation
- 2009-09-17 EP EP09786278.3A patent/EP2344523B1/en active Active
- 2009-09-17 JP JP2011527423A patent/JP5680536B2/ja active Active
- 2009-09-17 US US12/561,619 patent/US20100136041A1/en not_active Abandoned
- 2009-09-17 PL PL09786278.3T patent/PL2344523T3/pl unknown
- 2009-09-17 ES ES09786278.3T patent/ES2566740T3/es active Active
- 2009-09-17 AU AU2009334428A patent/AU2009334428B2/en active Active
- 2009-09-17 CN CN200980142304.9A patent/CN102356090B/zh active Active
- 2009-09-17 DK DK09786278.3T patent/DK2344523T3/da active
- 2009-09-17 HR HRP20160306TT patent/HRP20160306T1/hr unknown
- 2009-09-17 HU HUE09786278A patent/HUE027618T2/en unknown
- 2009-09-17 SI SI200931421A patent/SI2344523T1/sl unknown
- 2009-09-17 CA CA2737453A patent/CA2737453A1/en not_active Abandoned
- 2009-09-17 WO PCT/IB2009/006949 patent/WO2010076618A1/en not_active Ceased
-
2011
- 2011-03-16 ZA ZA2011/02005A patent/ZA201102005B/en unknown
-
2014
- 2014-11-13 US US14/540,627 patent/US20150132337A1/en not_active Abandoned
- 2014-11-25 JP JP2014237470A patent/JP2015038156A/ja not_active Withdrawn
-
2016
- 2016-04-29 SM SM201600125T patent/SMT201600125B/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009334428B2 (en) | 2014-02-20 |
| HUE027618T2 (en) | 2016-11-28 |
| MX2011002760A (es) | 2011-06-16 |
| US20100136041A1 (en) | 2010-06-03 |
| ZA201102005B (en) | 2016-09-28 |
| CA2737453A1 (en) | 2010-07-08 |
| JP2015038156A (ja) | 2015-02-26 |
| US20150132337A1 (en) | 2015-05-14 |
| EP2344523A1 (en) | 2011-07-20 |
| PL2344523T3 (pl) | 2016-09-30 |
| JP2012502969A (ja) | 2012-02-02 |
| BRPI0919236A8 (pt) | 2023-01-31 |
| CN102356090B (zh) | 2016-01-20 |
| HRP20160306T1 (hr) | 2016-04-22 |
| NZ591633A (en) | 2012-10-26 |
| SI2344523T1 (sl) | 2016-06-30 |
| JP5680536B2 (ja) | 2015-03-04 |
| SMT201600125B (it) | 2016-07-01 |
| ES2566740T3 (es) | 2016-04-15 |
| BRPI0919236A2 (pt) | 2015-12-15 |
| CN102356090A (zh) | 2012-02-15 |
| EP2344523B1 (en) | 2016-02-10 |
| AU2009334428A1 (en) | 2010-07-08 |
| WO2010076618A1 (en) | 2010-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2376791T3 (da) | Afstandsindretning og fastgørelsesindretning med afstandsindretning | |
| DK2467173T3 (da) | Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf | |
| DK2479174T3 (da) | 6-aminoquinazolin- eller 3-cyanquinolinderivater, fremstillingsfremgangsmåder og farmaceutiske anvendelser deraf | |
| DK2337568T3 (da) | Fremgangsmåder og midler til blødvævsteknologi | |
| CR10571A (es) | Vacuna virica recombinante | |
| DK2437830T4 (da) | Anordning til lægemiddelleveringsindretning og lægemiddelleveringsindretning | |
| DK3338790T3 (da) | Oligopeptid-forbindelser og anvendelser deraf | |
| DK3292874T3 (da) | Anti-mesothelin-immunkonjugater og anvendelser deraf | |
| DK2544719T3 (da) | Cd37-bindingsmolekyler og immunkonjugater deraf | |
| BRPI0919236A2 (pt) | terapêutica e vacinas de combinação de gas | |
| DK3241545T3 (da) | Siliciumdioxid-nanopartikler og anvendelse deraf til vaccination | |
| DK3067064T3 (da) | Modificerede rsv-f-proteiner og fremgangsmåder til anvendelse deraf | |
| DK2222675T3 (da) | 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse | |
| BRPI0907231A2 (pt) | pirrolpirimidinas e pirrolpiridinas | |
| DK2320911T3 (da) | Vasokonstriktionspræparater og fremgangsmåder til anvendelse deraf | |
| DK2490940T3 (da) | Uav-system og fremgangsmåde | |
| DK2220320T3 (da) | Forseglet enhed og mellemstykke | |
| DK2170827T3 (da) | Indolin-2-oner og aza-indolin-2-oner | |
| DK2160401T3 (da) | Fusionsmolekyler og il-15-varianter | |
| DE112010004462B8 (de) | Gasfüllsystem und gasfüllverfahren | |
| BRPI0909770A2 (pt) | Vacina, e, kit | |
| DE112010004411T8 (de) | Gasfüllvorrichtung und Gasfüllverfahren | |
| DK2337837T3 (da) | Alpha-amylase-blandinger og fremgangsmåder til anvendelse heraf | |
| FI20085334A0 (fi) | Harjoitusmenetelmä ja -järjestelmä | |
| DK2805746T3 (da) | Alkylamido-forbindelser og anvendelser deraf |